menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Lipid-Lowering Effects of Thyroid Hormone

close
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Dr. Larry Kaskel welcomes Dr. John Baxter to Lipid Luminations. Dr. Baxter is Senior Member at The Methodist Hospital in Houston, Texas as well at the Methodist Hospital Reasearch Institute. He will be discussing Thyroid Hormone Receptor Beta and Tissue Selective Uptake Antagonists. In particular, how they relate to the treatment of Atherosclerosis, Obesity and Diabetes. Selective thyroid hormone receptor subtype-beta (TRbeta) agonists have received attention as potential treatments for hypercholesterolemia and obesity, but have received less attention as treatments for diabetes.

    Brought to you by:

    NLA logo

     

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Dr. Larry Kaskel welcomes Dr. John Baxter to Lipid Luminations. Dr. Baxter is Senior Member at The Methodist Hospital in Houston, Texas as well at the Methodist Hospital Reasearch Institute. He will be discussing Thyroid Hormone Receptor Beta and Tissue Selective Uptake Antagonists. In particular, how they relate to the treatment of Atherosclerosis, Obesity and Diabetes. Selective thyroid hormone receptor subtype-beta (TRbeta) agonists have received attention as potential treatments for hypercholesterolemia and obesity, but have received less attention as treatments for diabetes.

    Brought to you by:

    NLA logo

     

Facebook Comments

Programs 9/27/21